The Use of Bioactive Glass S53P4 as Bone Graft Substitute in the Treatment of Chronic Osteomyelitis and Infected Non-Unions - a Retrospective Study of 50 Patients

被引:34
作者
Al Malat, Tarek [1 ]
Glombitza, Martin [1 ]
Dahmen, Janosch [1 ,2 ]
Hax, Peter-Michael [1 ]
Steinhausen, Eva [1 ,2 ]
机构
[1] BG Klinikum Duisburg, Klin Orthopadie & Unfallchirurg, Grossenbaumer Allee 250, D-47249 Duisburg, Germany
[2] Univ Witten Herdecke, Fak Gesundheit, Dept Humanmed, Witten, Germany
来源
ZEITSCHRIFT FUR ORTHOPADIE UND UNFALLCHIRURGIE | 2018年 / 156卷 / 02期
关键词
osteomyelitis; bioactive glass; bone substitute; antibacterial; osteoconductive; IN-VITRO; AUTOGENOUS BONE; BAG-S53P4; GRANULES; DEFECTS; GROWTH;
D O I
10.1055/s-0043-124377
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background Treatment of chronic osteomyelitis (COM) remains challenging and often results in large bone defects. Dead space management and proper defect filling are essential for successful treatment. Bioactive glass S53P4 (BAG-S53P4) is an anorganic bone graft substitute with antibacterial, osteoconductive, osteostimulative and angiogenic properties. The aim of our study was to analyse the outcome of patients with COM and infected non-unions, whose bone defects were filled with BAG-S53P4. Material and Methods In this retrospective study (07/1302/16), we analysed all patients with COM and infected non-unions, who obtained BAG-S53P4 after surgical debridement to fill their bone defects. Epidemiological data, pre-, peri- and postoperative characteristics were evaluated. The primary endpoint was the successful control of infection during the follow-up period. Secondary endpoints were the absence of BAG-S53P4-related complications, the time period to full weight bearing as well as to radiologically detectable incorporation of BAG. X-ray examinations were routinely performed 1 month, 3-4 months, 6 months and 12 months postoperatively. Results 50 patients were analysed. Staphylococcus aureus was the most common pathogen involved. On average, 11.1 +/- 6.7 cm(3) BAG-S53P4 were implanted. Mean follow-up was at 12.3 months. After 6 months, 26/37 (70.3%) and after 12 months, 35/42 (83.3%) of the filled bone defects were healed. X-ray examinations showed a thickened neo-cortex. 40 patients (80%) have achieved full weight bearing after a mean of 4 months. There were no complications at all in 76% of patients. Seven patients suffered reinfection. BAG-associated complications were not seen. Conclusions The use of BAG-S53P4 in patients with COM and infected non-unions is promising. Adequate debridement and proper defect filling are necessary. BAG is well tolerated. X-ray examinations showed a thickened neo-cortex. The antibacterial effect is not mediated by antibiotics and is advantageous in times of evolving antibiotic resistance. High quality studies with a longer follow-up are required.
引用
收藏
页码:152 / 159
页数:8
相关论文
共 30 条
[1]   Persistence of bacterial growth on antibiotic-loaded beads - Is it actually a problem? [J].
Anagnostakos, Konstantinos ;
Hitzler, Philip ;
Pape, Dietrich ;
Kohn, Dieter ;
Kelm, Jens .
ACTA ORTHOPAEDICA, 2008, 79 (02) :302-307
[2]  
Anderson GG, 2008, CURR TOP MICROBIOL, V322, P85
[3]   Bioactive glass for long bone infection: a systematic review [J].
Auregan, Jean-Charles ;
Begue, Thierry .
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2015, 46 :S3-S7
[4]   Antibiofilm agents against MDR bacterial strains: is bioactive glass BAG-S53P4 also effective? [J].
Bortolin, Monica ;
De Vecchi, Elena ;
Romano, Carlo Luca ;
Toscano, Marco ;
Mattina, Roberto ;
Drago, Lorenzo .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (01) :123-127
[5]   Efficacy of Antibacterial Bioactive Glass S53P4 Against S. aureus Biofilms Grown on Titanium Discs In Vitro [J].
Coraca-Huber, Debora C. ;
Fille, Manfred ;
Hausdorfer, Johann ;
Putzer, David ;
Nogler, Michael .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2014, 32 (01) :175-177
[6]   Bioactive glass stimulates the secretion of angiogenic growth factors and angiogenesis in vitro [J].
Day, RM .
TISSUE ENGINEERING, 2005, 11 (5-6) :768-777
[7]   In vitro antibiofilm activity of bioactive glass S53P4 [J].
Drago, Lorenzo ;
Vassena, Christian ;
Fenu, Simone ;
De Vecchi, Elena ;
Signori, Valentina ;
De Francesco, Raffaele ;
Romano, Carlo Luca .
FUTURE MICROBIOLOGY, 2014, 9 (05) :593-601
[8]   Bioactive glass BAG-S53P4 for the adjunctive treatment of chronic osteomyelitis of the long bones: an in vitro and prospective clinical study [J].
Drago, Lorenzo ;
Romano, Delia ;
De Vecchi, Elena ;
Vassena, Christian ;
Logoluso, Nicola ;
Mattina, Roberto ;
Romano, Carlo Luca .
BMC INFECTIOUS DISEASES, 2013, 13
[9]   THE IN VITRO ANTIBACTERIAL EFFECT OF S53P4 BIOACTIVE GLASS AND GENTAMICIN IMPREGNATED POLYMETHYLMETHACRYLATE BEADS [J].
Gergely, Istvan ;
Zazgyva, Ancuta ;
Man, Adrian ;
Zuh, Sandor Gyoergy ;
Pop, Tudor Sorin .
ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2014, 61 (02) :145-160
[10]   Bioactive glass granules: a suitable bone substitute material in the operative treatment of depressed lateral tibial plateau fractures: a prospective, randomized 1 year follow-up study [J].
Heikkila, Jouni T. ;
Kukkonen, Juha ;
Aho, Allan J. ;
Moisander, Susanna ;
Kyyronen, Timo ;
Mattila, Kimmo .
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 2011, 22 (04) :1073-1080